Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT vs TACE in Hepatocellular Carcinoma
NCT03338647Phase 3Unknown
- Sponsor
- Aarhus University
- Start
- Oct 2017
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Aarhus University. Primary endpoint: Progression (total of local, intra- and extrahepatic) at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT03338647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338647.